Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.

Abad R, Medina V, Fariñas MDC, Martínez-Martínez L, Bambini S, Dari A, Medini D, Pizza M, Vázquez JA.

J Infect. 2017 Dec;75(6):511-520. doi: 10.1016/j.jinf.2017.09.021. Epub 2017 Oct 5.

PMID:
28987549
2.

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.

Abad R, Medina V, Stella M, Boccadifuoco G, Comanducci M, Bambini S, Muzzi A, Vázquez JA.

PLoS One. 2016 Mar 7;11(3):e0150721. doi: 10.1371/journal.pone.0150721. eCollection 2016.

3.

Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.

Whelan J, Bambini S, Biolchi A, Brunelli B, Robert-Du Ry van Beest Holle M.

Expert Rev Vaccines. 2015 May;14(5):713-36. doi: 10.1586/14760584.2015.1004317. Epub 2015 Jan 21. Review.

PMID:
25603916
4.

Neisseria adhesin A variation and revised nomenclature scheme.

Bambini S, De Chiara M, Muzzi A, Mora M, Lucidarme J, Brehony C, Borrow R, Masignani V, Comanducci M, Maiden MC, Rappuoli R, Pizza M, Jolley KA.

Clin Vaccine Immunol. 2014 Jul;21(7):966-71. doi: 10.1128/CVI.00825-13. Epub 2014 May 7.

5.

Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.

Tzanakaki G, Hong E, Kesanopoulos K, Xirogianni A, Bambini S, Orlandi L, Comanducci M, Muzzi A, Taha MK.

BMC Microbiol. 2014 Apr 29;14:111. doi: 10.1186/1471-2180-14-111.

6.

Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Gasparini R, Comanducci M, Amicizia D, Ansaldi F, Canepa P, Orsi A, Icardi G, Rizzitelli E, De Angelis G, Bambini S, Moschioni M, Comandi S, Simmini I, Boccadifuoco G, Brunelli B, Giuliani MM, Pizza M, Panatto D.

J Clin Microbiol. 2014 Jun;52(6):1901-10. doi: 10.1128/JCM.03584-13. Epub 2014 Mar 19.

7.

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.

Holst J, Comanducci M, Bambini S, Muzzi A, Comandi S, Oksnes J, DeTora L, Pizza M, Rappuoli R, Caugant DA.

Vaccine. 2014 May 13;32(23):2722-31. doi: 10.1016/j.vaccine.2014.02.068. Epub 2014 Mar 12.

PMID:
24631075
8.

An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.

Bambini S, Piet J, Muzzi A, Keijzers W, Comandi S, De Tora L, Pizza M, Rappuoli R, van de Beek D, van der Ende A, Comanducci M.

PLoS One. 2013 May 24;8(5):e65043. doi: 10.1371/journal.pone.0065043. Print 2013.

9.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R.

Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.

PMID:
23414709
10.

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.

Wang X, Cohn A, Comanducci M, Andrew L, Zhao X, MacNeil JR, Schmink S, Muzzi A, Bambini S, Rappuoli R, Pizza M, Murphy E, Hoiseth SK, Jansen KU, Anderson AS, Harrison LH, Clark TA, Messonnier NE, Mayer LW.

Vaccine. 2011 Jun 24;29(29-30):4739-44. doi: 10.1016/j.vaccine.2011.04.092. Epub 2011 May 13.

PMID:
21571026
11.

Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.

Seib KL, Brunelli B, Brogioni B, Palumbo E, Bambini S, Muzzi A, DiMarcello F, Marchi S, van der Ende A, Aricó B, Savino S, Scarselli M, Comanducci M, Rappuoli R, Giuliani MM, Pizza M.

Infect Immun. 2011 Feb;79(2):970-81. doi: 10.1128/IAI.00891-10. Epub 2010 Dec 13.

12.

Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.

Brunelli B, Del Tordello E, Palumbo E, Biolchi A, Bambini S, Comanducci M, Muzzi A, Pizza M, Rappuoli R, Donnelly JJ, Giuliani MM, Serruto D.

Vaccine. 2011 Jan 29;29(5):1072-81. doi: 10.1016/j.vaccine.2010.11.064. Epub 2010 Dec 3.

PMID:
21130753
13.

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.

Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, Moxon ER, Stella M, Comanducci M, Bambini S, Muzzi A, Andrews W, Chen J, Santos G, Santini L, Boucher P, Serruto D, Pizza M, Rappuoli R, Giuliani MM.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19490-5. doi: 10.1073/pnas.1013758107. Epub 2010 Oct 20.

14.

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.

Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R.

Clin Vaccine Immunol. 2010 Jun;17(6):919-29. doi: 10.1128/CVI.00027-10. Epub 2010 Apr 7.

15.

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.

Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Kugelberg E, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Tang CM, Borrow R.

J Clin Microbiol. 2009 Nov;47(11):3577-85. doi: 10.1128/JCM.00936-09. Epub 2009 Sep 16.

16.

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, Comanducci M.

Vaccine. 2009 May 11;27(21):2794-803. doi: 10.1016/j.vaccine.2009.02.098. Epub 2009 Mar 10.

PMID:
19428890
17.

HadA is an atypical new multifunctional trimeric coiled-coil adhesin of Haemophilus influenzae biogroup aegyptius, which promotes entry into host cells.

Serruto D, Spadafina T, Scarselli M, Bambini S, Comanducci M, Höhle S, Kilian M, Veiga E, Cossart P, Oggioni MR, Savino S, Ferlenghi I, Taddei AR, Rappuoli R, Pizza M, Masignani V, Aricò B.

Cell Microbiol. 2009 Jul;11(7):1044-63. doi: 10.1111/j.1462-5822.2009.01306.x. Epub 2009 Mar 12.

PMID:
19290916
18.

The use of genomics in microbial vaccine development.

Bambini S, Rappuoli R.

Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Review.

PMID:
19150507
19.

A universal vaccine for serogroup B meningococcus.

Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M.

Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9. Epub 2006 Jul 6.

20.

Evaluation of the electromagnetic field level emitted by medium frequency AM broadcast stations.

Licitra G, Bambini S, Barellini A, Monorchio A, Rogovich A.

Radiat Prot Dosimetry. 2004;111(4):391-5.

PMID:
15550708
21.

Proteome analysis of Neisseria meningitidis serogroup A.

Bernardini G, Renzone G, Comanducci M, Mini R, Arena S, D'Ambrosio C, Bambini S, Trabalzini L, Grandi G, Martelli P, Achtman M, Scaloni A, Ratti G, Santucci A.

Proteomics. 2004 Oct;4(10):2893-926.

PMID:
15378741
22.

NadA diversity and carriage in Neisseria meningitidis.

Comanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, Capecchi B, Ciucchi L, Rappuoli R, Pizza M.

Infect Immun. 2004 Jul;72(7):4217-23.

23.

NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis.

Masignani V, Balducci E, Di Marcello F, Savino S, Serruto D, Veggi D, Bambini S, Scarselli M, Aricò B, Comanducci M, Adu-Bobie J, Giuliani MM, Rappuoli R, Pizza M.

Mol Microbiol. 2003 Nov;50(3):1055-67.

24.

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870.

Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M.

J Exp Med. 2003 Mar 17;197(6):789-99.

25.

NadA, a novel vaccine candidate of Neisseria meningitidis.

Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Aricò B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M.

J Exp Med. 2002 Jun 3;195(11):1445-54.

Supplemental Content

Loading ...
Support Center